Upload
dr-diana-enachescu
View
214
Download
0
Embed Size (px)
Citation preview
8/14/2019 The Malignant Couple
1/21
THE MALIGNANT COUPLE:THE MALIGNANT COUPLE:
PHENACETINPHENACETIN
NEPHROPATHY-NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
Scientific coordinatorsScientific coordinators::
MITITIUC IRINA,PhDMITITIUC IRINA,PhDHOGAS SIMONA,MDHOGAS SIMONA,MD
AuthorAuthor: Pricop Mariana: Pricop Mariana
CoauthorsCoauthors: Pricop Daniela: Pricop Daniela
Biru DianaBiru Diana
-Madalina-Madalina
8/14/2019 The Malignant Couple
2/21
PHENACETINPHENACETIN
Phenacetin, introduced in1887, was used principallyas an analgesic, and was
one of the first syntheticfever reducers to go on themarket.
It is also knownhistorically to be the firstanalgesic without anti-inflammatory properties.
8/14/2019 The Malignant Couple
3/21
PHENACETINPHENACETIN Phenacetin was widely used until the third quarter of
the twentieth century, but was then largely replacedby non-carcinogenic drugs.
Some branded phenacetin-based preparationscontinued to be sold, but with the phenacetinreplaced by safer alternatives.
A popular brand of phenacetin was Roche's Saridon,
which was reformulated in 1983 to containpropyphenazone, paracetamol and caffeine.
Paracetamol is a metabolite of phenacetin withsimilar analgesic and antipyretic effects, but the new
formulation has not been found to have phenacetin'scarcino enicit .
8/14/2019 The Malignant Couple
4/21
PHENACETINPHENACETIN
NEPHROPATHY-NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS Analgesic nephropathy occurs in about 4 out of
100,000 people, mostly women over 30. The rate hasdecreased significantly since phenacetin is no longerwidely available in OTC preparations.
Risk factors include:* Use of OTC analgesics containing more than one
active ingredient
* Chronic headache
* Chronic backache or musculoskeletal pain* Emotional or behavioral changes
* History of dependent behaviors including smoking,alcoholism, and excessive use of tranquilizers
* Pain with menstrual periods
8/14/2019 The Malignant Couple
5/21
The cardinal features of the AnalgesicSyndrome:
PHENACETINPHENACETIN
NEPHROPATHY-NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
6/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
In general, phenacetin is metabolized by
acetaminophen after dehydration in the liver andthereafter it undergoes either sulfate acid orglutamic conjugation in the kidneys;
The remaining free phenacetin is then excreted into
the urine. Excessive acetaminophen results in thedepletion of glutathione and the accumulation ofacetaminophen oxides and an activated reactionmay thus occur.
8/14/2019 The Malignant Couple
7/21
The reflux of acetaminophen into the kidneys and itsconcentration in the renal medulla contribute to theinhibition of prostaglandin synthesis, thus leading torenal medullary ischemia and renal papillarynecrosis.
The resulting tubular obstruction promotes anenlargement of the renal cortex and the formation of
a histological background of interstitinal nephritis.
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
8/21
Regarding the development of urotherial tumorassociated with phenacetin abuse, N-hydroxylationproducts, the intermediate metabolite of phenacetinsuch as N-hydroxy-p-phenetidine and 2-hydroxyphetidine, seemed to be potentialcarcinogens.
The process of carcinogenesis in urotherium byexposure of the potential carcinogens in phenacetinmetabolic products are considered to take at least10 years under excessive .
Therefore, almost all reported cases of urotherial
tumor associated with phenacetin abuse had ahistory of excessive phenacetin use for more than 10
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
9/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
10/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
11/21
PHENACETIN ABUSEPHENACETIN ABUSE
Double target onDouble target on
reno-urinary systemreno-urinary system
8/14/2019 The Malignant Couple
12/21
Specific kidney injuriesSpecific kidney injuries renal papillary necrosisrenal papillary necrosis
-- chronic interstitial nephritischronic interstitial nephritis (the neprhopathy is a result from decreased blood flow to
the kidneyrapid consumption of antioxidants subsequent oxidative
damage )
This damage may lead to progressive chronic renalThis damage may lead to progressive chronic renalfailure, abnormal urinalysisfailure, abnormal urinalysisresults high blood pressure and anemia. Aresults high blood pressure and anemia. A
proportion of individuals with phenacetinproportion of individuals with phenacetinnephropathy may develop end-stage kidney disease.nephropathy may develop end-stage kidney disease.
Also the phenacetin abuse is directly related to theAlso the phenacetin abuse is directly related to theurothelial tumors.urothelial tumors.
Phenacetin abuse-daily consume for at least 5ears minimum total dose=2-7k
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
13/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
Drug-induced acute interstitialnephritis
8/14/2019 The Malignant Couple
14/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
Papillary necrosis
8/14/2019 The Malignant Couple
15/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
16/21
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
17/21
B.I.,male,65years old,PascaniB.I.,male,65years old,Pascani
1978-amputation left leg1978-amputation left leg
Pain in the amputated leg -> chronical abuse ofPain in the amputated leg -> chronical abuse ofphenacetinphenacetin --3-603-60 tablets/daytablets/day forfor 19 years19 years ((3030 kgkg))
MicroscopicMicroscopic hematury-high suspicion of vesicalhematury-high suspicion of vesicaltumorstumors
1997-phenacetin nephropathy1997-phenacetin nephropathy
--
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
18/21
S.F.,female,75years old,IasiS.F.,female,75years old,Iasi
Abuse of phenacetin-headaches->Abuse of phenacetin-headaches->3-6 tablets/day for3-6 tablets/day for
2020 years(4-8kg)years(4-8kg)
2000-CRF stage 5,peritoneal dialysis2000-CRF stage 5,peritoneal dialysis
2001-after 5 episode of peritonitis->hemodialysis2001-after 5 episode of peritonitis->hemodialysis
2007-2007-multiplemultiple vesical tumorsvesical tumors ->endoscopic resection->endoscopic resection
2009-fever with unknown etiology-suspicion of2009-fever with unknown etiology-suspicion ofmetastasismetastasis
PHENACETIN NEPHROPATHY-PHENACETIN NEPHROPATHY-
UROTHELIAL TUMORSUROTHELIAL TUMORS
8/14/2019 The Malignant Couple
19/21
Conclusionsin memoriam phenacetinnephropathy
The asociation between phenacetin and urothelialtumors is a reality .
Every patient with phenacetin nephropathy needs
to be closely observed for urothelial tumors
The cases of phenacetin nephropathy are amongthe last ones because products containingphenacetin the drug was withdrawn from the market
in Western countries in the 1980s and also in Japanin 2001.
The evolution is slowly progression to chronic renalfailure
Stoping the phenacetin ingestion can stabilize the
8/14/2019 The Malignant Couple
20/21
Stop to the consumption of over thecounter pain medications!
It could affect permanently andirreversible your reno-urinary system!
8/14/2019 The Malignant Couple
21/21THANK YOU!THANK YOU!